Caterina A M La Porta Selected Research

Caterina A M La Porta Research Topics

Disease

19	Melanoma (Melanoma, Malignant) 02/2024 - 05/2002
15	Neoplasms (Cancer) 02/2024 - 05/2004
7	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2007
2	Triple Negative Breast Neoplasms 02/2024 - 03/2023
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2013
1	COVID-19 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2020
1	Stroke (Strokes) 06/2020
1	Progeria (Hutchinson Gilford Syndrome) 01/2020
1	Huntington Disease (Huntington's Disease) 01/2019
1	Familial encephalopathy with neuroserpin inclusion bodies 01/2017
1	Rare Diseases (Rare Disease) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Nervous System Diseases (Neurological Disorders) 04/2014
1	Leukemia 09/2012
1	Mercury Poisoning (Poisoning, Mercury) 02/2008
1	Carcinoma (Carcinomatosis) 01/2006

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2010
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2014
2	LaminsIBA 12/2022 - 01/2020
2	CalciumIBA 08/2021 - 05/2002
2	MicroRNAs (MicroRNA)IBA 12/2019 - 10/2015
2	Protein Isoforms (Isoforms)IBA 08/2002 - 05/2002
1	Ion Channels (Ion Channel)IBA 08/2021
1	Oxidants (Oxidizing Agents)IBA 08/2021
1	Complement System Proteins (Complement)IBA 08/2021
1	PotassiumIBA 08/2021
1	Potassium Channels (Potassium Channel)IBA 08/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	SmokeIBA 06/2020
1	ChromatinIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Lamin Type A (Lamin A)IBA 01/2020
1	Polycomb-Group ProteinsIBA 01/2020
1	Circular RNAIBA 12/2019
1	PrionsIBA 01/2019
1	polyglutamineIBA 01/2019
1	Huntingtin ProteinIBA 01/2019
1	NeuroserpinIBA 01/2017
1	Adapalene (Differin)FDA LinkGeneric 10/2015
1	CollagenIBA 01/2014
1	LigandsIBA 12/2012
1	CytokinesIBA 12/2012
1	ChemokinesIBA 12/2012
1	Mercuric Chloride (Sublimate)IBA 09/2012
1	MercuryIBA 09/2012
1	Thimerosal (Thiomersal)IBA 09/2012
1	VaccinesIBA 09/2012
1	Local Anti-Infective Agents (Antiseptics)IBA 09/2012
1	SurvivinIBA 01/2012
1	Actins (F Actin)IBA 07/2009
1	Aquaporins (Water Channels)IBA 10/2007
1	Angiogenesis InhibitorsIBA 01/2007
1	BBR 3464 (BBR3464)IBA 01/2006
1	Platinum Compounds (Compounds, Platinum)IBA 01/2006
1	Protein Kinase C-deltaIBA 06/2005
1	phosphatidylcholine-ceramide phosphocholine transferaseIBA 06/2005
1	Protein Kinases (Protein Kinase)IBA 06/2005
1	Glucose (Dextrose)FDA LinkGeneric 10/2004
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2004
1	Melanins (Melanin)IBA 08/2002
1	Protein Kinase CIBA 08/2002
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2002
1	calcium-independent protein kinase CIBA 05/2002
1	Interferon-alpha (Interferon Alfa)IBA 05/2002
1	Dacarbazine (DIC)FDA LinkGeneric 05/2002

Therapy/Procedure

7	Therapeutics 02/2024 - 05/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 05/2002
3	Precision Medicine 01/2021 - 01/2017
1	Immunotherapy 02/2024
1	Neoadjuvant Therapy 03/2023
1	Radiotherapy 05/2004
1	Biological Therapy 05/2002
1	Combination Drug Therapy (Combination Chemotherapy) 05/2002